BioFire Diagnostics, LLC recalls BioFire Respiratory Panel 2.1 plus Kit

Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.

On April 30, 2025, Biomerieux issued a "Urgent Field Safety Notice" to affected consignees via email. Biomerieux asked consignees to take the following actions: 1. Immediately examine your inventory for the lot identified in this field safety notice. 2. Discontinue use and discard any remaining product from this lot in your possession. 3. As previously confirmed discontinued use of product, please confirm the amount of kits destroyed on the attached Acknowledgement of Receipt Form. 4. If you have further distributed this product, please identify any recipients and notify them at once. 5. Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification.

• FDA enforcement recordOfficial FDA database entry for Z-1877-2025
• FDA device classification · OCCOfficial FDA classification for this device type
• CFR regulation · 21 CFR 866.3980The federal regulation governing this device
• FDA recall announcementSearch FDA.gov for the official press announcement
• Find BioFire Diagnostics, LLCSearch for the manufacturer's official notice
• News coverageRecent reporting on this recall and manufacturer
• openFDA data recordThe raw JSON record this page is built from

Source: U.S. FDA openFDA device enforcement reports. This summary is informational and may lag or differ from the official record. Always verify against the FDA before acting.